e-learning
resources
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A specific proteinase 3 activity footprint in a
1
-antitrypsin deficiency
Paul R. Newby, Diana Crossley, Helena Crisford, James A. Stockley, Richard A. Mumford, Richard I. Carter, Charlotte E. Bolton, Nicholas S. Hopkinson, Ravi Mahadeva, Michael C. Steiner, Tom M.A. Wilkinson, Elizabeth Sapey, Robert A. Stockley
Source:
ERJ Open Res, 5 (3) 00095-2019; 10.1183/23120541.00095-2019
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Paul R. Newby, Diana Crossley, Helena Crisford, James A. Stockley, Richard A. Mumford, Richard I. Carter, Charlotte E. Bolton, Nicholas S. Hopkinson, Ravi Mahadeva, Michael C. Steiner, Tom M.A. Wilkinson, Elizabeth Sapey, Robert A. Stockley. A specific proteinase 3 activity footprint in a
1
-antitrypsin deficiency. ERJ Open Res, 5 (3) 00095-2019; 10.1183/23120541.00095-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004
Proteinase 3 activity is present in sputum from subjects with alpha-1-antitrypsin deficiency (AATD) and COPD
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
A neo-epitope of serum lysyl oxidase like 2 (LOXL2) generated during enzyme maturation is elevated in cancer and idiopathic pulmonary disease
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
The role of serum cathepsin S levels in sarcoidosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vitro
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
a
1
-antitrypsin deficiency
Source: Eur Respir Monogr 2015; 69: 47-84
Year: 2015
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of α1-antitrypsin deficiency in Asia
Source: Eur Respir J 2006; 28: 1091-1099
Year: 2006
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Inhibition of elastinolytic activity in induced sputum from COPD patients and healthy controls by recombinant alpha 1-antitrypsin (rAAT) and a fusion protein, TAPI
Source: Eur Respir J 2004; 24: Suppl. 48, 471s
Year: 2004
Plasma level of Mannose-binding lectin-associated serine protease (MASP-2) concentration in children with asthma.
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
HLA class II alleles are associated with development of emphysema in alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008
The effects of recombinant human active protein C on inflammation and NOS in sepsis
Source: Eur Respir J 2005; 26: Suppl. 49, 221s
Year: 2005
Neutral endopeptidase activity is reduced by ascorbic acid in primary cultures of alveolar type II cells
Source: Eur Respir J 2004; 24: Suppl. 48, 555s
Year: 2004
Mannan-binding lectin (MBL) structural gene mutations, promoter polymorphism and circulating protein levels in pulmonary tuberculosis
Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis
Year: 2003
Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years
Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Year: 2003
Modification of gene expression and increase in alpha-1-antitrypsin (α
1
AT) secretion after homologous recombination in α
1
AT deficient monocytes
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007
Effect of proteinase inhibitor from
crataeva tapia
(cratabl) in distal lung mechanical, inflammatory and remodeling alterations induced by elastase in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept